SAN DIEGO — Eurofins Discovery announced a Founding Partner sponsorship agreement with BioLabs San Diego., providing support for premium wet lab and shared office facilities for early-stage life science entrepreneurs and developing first-in-class therapeutic tools and products with Eurofins DiscoverX.
Eurofins Pharma Discovery Services has acquired DiscoverX, enabling the expanded company to provide even more products, services, and integrated drug discovery projects from a single outsourcing provider.
The combination of Eurofins Pharma Discovery Services and DiscoverX provides the pharmaceutical and biotech industries with a partner of choice for end-to-end drug discovery services, DiscoverX’s KINOMEscan platform and epigenetics services, combined with Eurofins Pharma Discovery’s kinase profiling services would result in the largest available portfolio of kinase products and services in the market.
Fremont, CA – DiscoverX Corporation launches PathHunter® checkpoint receptor screening and profiling services, providing validated assays for characterizing the increasing number of new immuno-oncology targets.
Announcing the InCELL Pulse™ target engagement platform
Announcing the launch of the SAFETYscan™ in vitro pharmacological profiling services
Announcing PathHunter® β-Arrestin Retroparticles
Announcing the launch of the KILR™ Retropartices
DiscoverX partners with the Structural Genomics Consortium (SGC)
Announcing the launch of the KILR™ Cytotoxicity Assay